Trifezolac
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384619This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XJ3W180C22. European Medicines Agency schedules Trifezolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11283MIG. Trifezolac generally arises in the molecular formula C23H18N2O2. The term TRIFEZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) TRIFEZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trifezolac under HS 29331990 and SITC 51571. As of Q4 2014, TRIFEZOLAC remains the US FDA Preferred Term for this commodity. Trifezolac bears US NLM identifiers UMLS ID C2700077 and NCI Concept Code C76824. SMILES: OC(=O)CC1C(N(NC1C1CCCCC1)C1CCCCC1)C1CCCCC1.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.